In this episode of MedInsights Unleashed, Dr. Oliver Bathe MD FRCSC, Professor of Surgery and Oncology University, CEO Qualisure Diagnostics Inc. discusses his journey from surgical oncology to pioneering precision cancer care. He delves into the role of machine learning in analyzing vast genomic databases to personalize treatment and improve patient outcomes. Dr. Bathe shares personal insights, emphasizing the importance of tailoring cancer therapies to individual patients. The podcast explores the creation and application of diagnostic tests, like those for thyroid cancer, which offer more targeted treatment options and hope for patients confronting a complex healthcare landscape.
Qualisure Diagnostics Inc contact information:
Oliver F. Bathe, MD – CEO & Founder
3655 36th Street NW Calgary, Alberta T2L 1Y8
p: +1 403.614.7124
